Reata Pharmaceuticals Inc

BANK OF AMERICA CORP /DE/

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/14/2023

Shares

87,846

Value ($000)

8,957

Weight

0.0%

2019 Q4 - 2023 Q2 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/14/2023	8,957	0.0%	87,846	6/30/2023
2023 Q1	5/12/2023	20,157	0.0%	221,696	3/31/2023
2022 Q4	2/10/2023	7,712	0.0%	203,011	12/31/2022
2022 Q3	11/14/2022	4,286	0.0%	170,536	9/30/2022
2022 Q2	8/12/2022	2,697	0.0%	88,741	6/30/2022
2022 Q1	5/16/2022	2,559	0.0%	78,132	3/31/2022
2021 Q4	2/8/2022	2,511	0.0%	95,218	12/31/2021
2021 Q3	11/15/2021	8,915	0.0%	88,611	9/30/2021
2021 Q2	9/13/2021	8,415	0.0%	59,453	6/30/2021
2021 Q1	5/14/2021	8,197	0.0%	82,229	3/31/2021
2020 Q4	2/10/2021	8,066	0.0%	65,258	12/31/2020
2020 Q3	11/13/2020	5,977	0.0%	61,353	9/30/2020
2020 Q2	8/14/2020	9,995	0.0%	64,052	6/30/2020
2020 Q1	5/15/2020	13,731	0.0%	95,132	3/31/2020
2019 Q4	2/14/2020	18,759	0.0%	91,766	12/31/2019